Delisting riskPopularity #4,472
Aspire Biopharma (ASBP)
Developer of sublingual drug and supplement formulations, including aspirin candidates and Buzz Bomb.
$8.20
After hours−0.01 (−0.17%)
At close$8.21(−5.80%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Nov '24Apr '25May '25Aug '25Nov '25Mar '26May '26Aug '26
Reported−$0.02−$0.28−$16.80−$0.04−$0.04−$3.15−$20.57−$1.00
Estimate————————
Surprise————————
RevenueReportedEstimate
Nov '24Apr '25May '25Aug '25Nov '25Mar '26May '26Aug '26
Reported————$1.9K$4.3K$28.4K$63.1K
Estimate————————
Surprise————————
History
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | — | −$1.00 | — |
| May 2026 | — | −$20.57 | — |
| Mar 2026 | — | −$3.15 | — |
| Nov 2025 | — | −$0.04 | — |
| Aug 2025 | |||
| May 2025 | |||
| Apr 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Jun 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | — | −$1.00 | — | — | $63.1K | — | −0.3% |
| May 15, 2026 | — | −$20.57 | — | — | $28.4K | — | −4.4% |
| Mar 30, 2026 | — | −$3.15 | — | — | $4.3K | — | +8.4% |
| Nov 14, 2025 | — | −$0.04 | — | — | $1.9K | — | +1.0% |
| Aug 13, 2025 | |||||||
| May 14, 2025 | |||||||
| Apr 7, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 16, 2024 | |||||||
| Jun 5, 2024 | |||||||
| Mar 11, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 21, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 16, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Sep 30, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 |